ELOX · Eloxx Pharmaceuticals, Inc.
$18.53
-0.76 (-3.94%)
At close · Aug 26
Going-concern doubt
— cleared Aug 11, 2026
The latest filing no longer states the doubt (first flagged May 5, 2026).
View the 10-Q filed Aug 11, 2026Market Cap
$77.86M
Shares
4.04M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Nina Kjellson | Director | Appointed | 2026-06-01 |
| Stephen W. Webster | Director | Appointed | 2026-06-01 |
| Lindsay Androski | Board | Resigned | 2025-08-12 |
| Tomer Kariv | Board of Directors | Resigned | 2023-12-28 |
| Tomer Kariv | Chairman of the Board | Resigned | 2023-12-28 |
| Dr. Vijay Modur | Head of Research and Development | Resigned | 2023-09-15 |
| Lindsay Androski | Director | Appointed | 2022-07-05 |
| Rajesh Parekh | Director | Resigned | 2022-07-05 |
| Gadi Veinrib | Director | Resigned | 2022-07-05 |
| Jasbir Seehra | Director | Resigned | 2022-07-05 |
| Zafrira Avnur | Director | Resigned | 2022-07-05 |
| Ran Nussbaum | Director | Resigned | 2022-07-05 |
| Daniel Geffken | Principal Accounting Officer | Appointed | 2021-08-20 |
| Gary Rakers | Executive Director, Finance & Accounting, Corporate Controller and Treasurer (Principal Accounting Officer) | Resigned | 2021-07-16 |
| Raj Parekh, Ph.D. | Director | Appointed | 2021-04-01 |
| Alan Walts, Ph.D. | Director | Appointed | 2021-04-01 |
| Vijay Modur, M.D., Ph.D. | Head of Research and Development | Appointed | 2021-04-01 |
| Raj Parekh | Parent Board | Appointed | 2021-04-01 |
| Sumit Aggarwal | Parent Board | Appointed | 2021-04-01 |
| Vijay Modur | Head of Research & Development | Appointed | 2021-04-01 |
| Alan Walts | Parent Board | Appointed | 2021-04-01 |
| Sumit Aggarwal | Chief Executive Officer of the Company | Appointed | 2021-04-01 |
| Gregory C. Williams | Chief Executive Officer | Resigned | 2021-04-01 |
| Daniel Geffken | Interim Chief Financial Officer | Appointed | 2021-04-01 |
| Rajesh Parekh | Eloxx Board | Appointed | 2021-04-01 |